Bolt Biotherapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BOLT and other ETFs, options, and stocks.

About BOLT

Bolt Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer. Its pipeline includes BDC-1001, a HER2-targeting Boltbody Immune-Stimulating Antibody Conjugate (ISAC), BDC-3042, a myeloid-modulating antibody, and multiple Boltbody ISAC collaboration programs. 

CEO
William P. Quinn
CEOWilliam P. Quinn
Employees
52
Employees52
Headquarters
Redwood City, California
HeadquartersRedwood City, California
Founded
2015
Founded2015
Employees
52
Employees52

BOLT Key Statistics

Market cap
12.92M
Market cap12.92M
Price-Earnings ratio
-0.30
Price-Earnings ratio-0.30
Dividend yield
Dividend yield
Average volume
26.25K
Average volume26.25K
High today
$6.76
High today$6.76
Low today
$6.26
Low today$6.26
Open price
$6.27
Open price$6.27
Volume
17.48K
Volume17.48K
52 Week high
$10.92
52 Week high$10.92
52 Week low
$4.41
52 Week low$4.41

Stock Snapshot

With a market cap of 12.92M, Bolt Biotherapeutics(BOLT) trades at $6.68. The stock has a price-to-earnings ratio of -0.30.

On 2026-01-24, Bolt Biotherapeutics(BOLT) stock moved within a range of $6.26 to $6.76. With shares now at $6.68, the stock is trading +6.7% above its intraday low and -1.2% below the session's peak.

Trading activity shows a volume of 17.48K, compared to an average daily volume of 26.25K.

Over the past 52 weeks, Bolt Biotherapeutics(BOLT) stock has traded between a high of $10.92 and a low of $4.41.

Over the past 52 weeks, Bolt Biotherapeutics(BOLT) stock has traded between a high of $10.92 and a low of $4.41.

People also own

Based on the portfolios of people who own BOLT. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.